LLY receives exclusive, target-specific rights for licensed products
Hammerstone MarketTalk says LLY will receive exclusive, target-specific rights to develop and commercialize licensed products directed to collaboration targets under an Amplitude Therapeutics arrangement.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.